Viewing Study NCT04648202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-04-25 @ 8:48 AM
Study NCT ID: NCT04648202
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-27
First Post: 2020-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: FS120 Phase 1/1b Study in Patients With Advanced Malignancies
Sponsor: invoX Pharma Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immuno-oncology View
None Bispecific antibody View
None Dose escalation View
None Cohort expansion View
None OX40 View
None CD137 (4-1BB) View
None invoX View
None Pembrolizumab View
None PD-1 View